Navan Stock Down From IPO: New $274M Stake Signals Conviction
Navan stock down from its IPO price has dropped sharply, but a major investor just built a substantial stake. Here’s ...
Adjusting your budget mid month can help you stay on track with your financial goals. Discover the best times to make these changes.
23,727 articlesNavan stock down from its IPO price has dropped sharply, but a major investor just built a substantial stake. Here’s ...
A notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
In 2026, JEPI remains a go-to for retirement income, yet Amplify DIVO is delivering stronger total returns for some i...
A practical, no-fluff look at national health investors (nhi) after its Q4 update. We break down occupancy, rent coll...
In a volatile market, Hyperliquid is turning heads with its HYPE token and HIP-3 pre-IPO perps. This piece breaks dow...
As markets shift in mid-2026, investors and borrowers weigh whether shelter costs or the stock market deliver stronge...
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Goldman Sachs argues that a rapid, AI-driven reordering of jobs remains unlikely. There’s little evidence of a broad ...
Two leading midstream ETFs, AMLP and MLPX, battle for income and tax efficiency as the 2026 energy rally persists. Th...
A major fund trimmed its LKQ position by 777,000 shares, raising questions about what this means for the stock and th...
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
As markets wobble in early 2026, investors are increasingly pursuing a hybrid approach that blends bonds and dividend...